Recent studies have shown cannabidiol (CBD) has numerous pharmacological targets that initiate anti-inflammatory, antioxidative, and antiepileptic properties. It also highlights the positive effects it can have on the brain even in extreme events such as traumatic brain injury.

Further studies have also highlighted evidence around the endocannabinoid system (ECS) and CBD. The ECS is a neurochemical network that regulates bodily functions such as pain, emotions and sleep and CBD can affect the body via the ECS. In fact studies have shown that CBD induces significant alterations in brain activity and connectivity patterns whilst in the brain is in resting state, and whilst performing cognitive tasks. 

Other research has also demonstrated the effect cold pressed CDD has over isolate. Including the additional benefits of terpenes and flavonoids have in increasing the overall effects CBD when ingested.

Furthermore, caffeine is a widely researched compound, which comes from coffee. Several studies have shown the science behind caffeine including how it impacts on adenosine receptors in our brain. Adenosine causes muscle relaxation and sleepiness when it acts on these receptors and caffeine blocks the adenosine from binding to these receptors, and when it does, it prevents the adenosine from building up, preventing the feeling of fatigue and drowsiness.